Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T0LU
|
||||
Former ID |
DAP000818
|
||||
Drug Name |
Conjugated Estrogens
|
||||
Synonyms |
Carentil; Climarest; Congest; Dagynil; Estroplus; Evex; Femavit; Menotabs; Oestrofeminal; Oestrogen; Prelestrin; Premarin; Presomen; Presomil; Progens; Transannon; Conjugated Equine Estrogens; Conjugated Estrogenic Substances; Conjugated estrogenic hormones; Conjugated oestrogens; Conjugated oestrogens [Steroidal oestrogens]; Estrogens conjugated; Par Estro; Steroidal estrogens; ASTA Medica Brand of Estrogens, Conjugated; Almirall Brand of Estrogens, Conjugated; Equine Estrogens, Conjugated; Estro-Feminal; Estrogenic Hormones, Conjugated; Estrogenic substances, conjugated; Estrogens, Conjugated; Estrogens, conjugated USP; Estrogens, conjugated [USP]; Estrogens, conjugated synthetic A; Estrogens, steroidal; Estrone, hydrogen sulfate sodium salt; Oestro-feminal; Sodium estrone 3-monosulfate; Solvay Brand of Estrogens, Conjugated; Trianon Brand of Estrogens, Conjugated; Wyeth Brand of Estrogens, Conjugated; Estrogens, conjugated (USP); Estrogens, conjugated-equine; Mack Brand of Estrogens, Conjugated (USP); Major Brand of Estrogens, Conjugated (USP); Pasadena Brand of Estrogens, Conjugated (USP); Pharmacia Brand of Estrogens, Conjugated (USP); C.E.S.; Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, sodium salt; Sodium [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Estrogens
|
||||
Company |
Wyeth Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H22NaO5S+
|
||||
Canonical SMILES |
CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.[Na+]
|
||||
InChI |
1S/C18H22O5S.Na/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22);/q;+1/t14-,15-,16+,18+;/m1./s1
|
||||
InChIKey |
VUCAHVBMSFIGAI-ZFINNJDLSA-N
|
||||
CAS Number |
CAS 438-67-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
ChEBI ID |
ChEBI:8389
|
||||
SuperDrug ATC ID |
G03CA57
|
||||
Target and Pathway | |||||
Target(s) | Estrogen receptor beta | Target Info | Antagonist | [535660], [536952] | |
KEGG Pathway | Estrogen signaling pathway | ||||
Prolactin signaling pathway | |||||
References | |||||
Ref 529091 | Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status. Breast. 2008 Apr;17(2):172-9. Epub 2007 Oct 24. | ||||
Ref 536361 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. | ||||
Ref 535660 | Knockouts model the 100 best-selling drugs--will they model the next 100? Nat Rev Drug Discov. 2003 Jan;2(1):38-51. | ||||
Ref 536952 | Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination. Mol Endocrinol. 2009 Jan;23(1):74-85. Epub 2008 Nov 26. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.